Teehan Brendan

CIK 00018919002 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001891900

Recent Transactions

50 trades

Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-02-11+51,714→ 100,934.268 total
Tax Payment
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-01-30$20.54/sh−5,182→ 49,220.268 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-12-31$10.76/sh+402.268→ 54,402.268 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2025-02-04$26.59/sh+99,500→ 99,500 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-02-01+54,000→ 54,000 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-19$16.81/sh−10,329→ 62,105 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-17+9,913→ 62,521 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-17+9,913→ 72,434 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-11-17−9,913→ 9,913 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-11-17−9,913→ 9,913 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-19$15.28/sh−9,534→ 52,177 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+5,024→ 48,082 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+13,629→ 61,711 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-02$16.94/sh−3,477→ 42,133 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-01−6,814→ 20,445 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-01+6,814→ 45,610 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−2,568→ 38,796 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−5,024→ 10,048 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+5,024→ 41,364 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-27$17.90/sh−5,140→ 36,340 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-25+10,048→ 41,480 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Options (Right to Buy)
2024-03-25+89,516→ 89,516 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-03-25+27,460→ 27,460 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-26$24.67/sh−624→ 31,432 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-02-23−1,107→ 1,107 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-23+1,107→ 32,056 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-08$29.96/sh−731→ 30,949 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-01-06−1,287→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-06+1,287→ 31,680 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-11-20$22.64/sh−4,960→ 30,393 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-11-17−4,956→ 19,826 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-11-17−4,956→ 19,826 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-11-17+4,956→ 30,397 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-11-17+4,956→ 35,353 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-05-17−14,869→ 24,782 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-05-17$22.50/sh−14,869→ 24,356 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-05-17+14,869→ 24,356 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-05-17+14,869→ 39,225 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-05-17−14,869→ 24,782 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-05-01$21.18/sh−548→ 9,487 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-05-01+27,259→ 27,259 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Options (Right to Buy)
2023-05-01+89,936→ 89,936 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-04-29−1,567→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-29+1,567→ 10,035 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-06$18.16/sh−1,751→ 8,468 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-05+5,024→ 10,219 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-04-05−5,024→ 15,072 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-24$18.78/sh−461→ 5,195 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-23+1,107→ 5,656 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-02-23−1,107→ 2,214 total

Companies

Recent Filings

Address

C/O PACIRA BIOSCIENCES, INC. 2000 SIERRA POINT PARKWAY, SUITE 900

BRISBANE, CA, 94005

View on SEC.gov